Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription factor binding	TRERF1 CCNT2 SETD1A NCOR2 NCOA6 CRTC3 PTPRN EGR2 NFATC4 KDM5C SIN3A MED1 SPEN TOX2 HDAC7 TBX5	5.83e-08	753	82	16	GO:0008134
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	TRERF1 SETD1A NCOR2 NCOA6 CRTC3 EGR2 KDM5C SIN3A MED1 SPEN TOX2 HDAC7 TBX5	6.78e-07	582	82	13	GO:0140297
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	TRERF1 SETD1A NCOR2 NCOA6 EGR2 KDM5C SIN3A MED1 SPEN TOX2 TBX5	1.07e-06	417	82	11	GO:0061629
GeneOntologyMolecularFunction	transcription coregulator activity	TRERF1 NCOR2 NCOA6 ZMIZ2 NFKBIZ SIN3A MED1 CBFA2T3 SPEN TOX2 HDAC7 TRIM52	3.03e-06	562	82	12	GO:0003712
GeneOntologyMolecularFunction	transcription corepressor activity	TRERF1 NCOR2 SIN3A MED1 CBFA2T3 SPEN HDAC7	4.36e-05	229	82	7	GO:0003714
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	NCOA6 NFATC4 MED1	8.42e-05	21	82	3	GO:0042975
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	TRERF1 NCOA6 ZMIZ2 MED1	1.15e-04	61	82	4	GO:0030374
GeneOntologyMolecularFunction	chromatin binding	CCNT2 NCOR2 NCOA6 ATF5 EGR2 GLI1 SIN3A MED1 CBFA2T3 TOX2 HDAC7	2.12e-04	739	82	11	GO:0003682
GeneOntologyMolecularFunction	SUMO transferase activity	EGR2 ZMIZ2 HDAC7	4.32e-04	36	82	3	GO:0019789
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	SETD1A SETD1B	4.59e-04	8	82	2	GO:0140945
GeneOntologyMolecularFunction	histone H3K4 trimethyltransferase activity	SETD1A SETD1B	7.34e-04	10	82	2	GO:0140999
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	TRERF1 NCOR2 NCOA6 ZMIZ2 DVL2 NFKBIZ SIN3A MED1 CBFA2T3 SPEN TOX2 HDAC7 TRIM52	8.48e-04	1160	82	13	GO:0030674
GeneOntologyMolecularFunction	transcription coactivator binding	TRERF1 CCNT2 MED1	1.42e-03	54	82	3	GO:0001223
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	NCOR2 NCOA6 MED1	1.50e-03	55	82	3	GO:0042974
GeneOntologyMolecularFunction	transcription coactivator activity	TRERF1 NCOA6 ZMIZ2 MED1 TOX2 TRIM52	1.55e-03	303	82	6	GO:0003713
GeneOntologyMolecularFunction	nuclear vitamin D receptor binding	NCOA6 MED1	2.44e-03	18	82	2	GO:0042809
GeneOntologyMolecularFunction	nuclear glucocorticoid receptor binding	NCOR2 NCOA6	3.02e-03	20	82	2	GO:0035259
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	SETD1A SETD1B	3.02e-03	20	82	2	GO:0042800
GeneOntologyMolecularFunction	SUMO ligase activity	EGR2 ZMIZ2	3.02e-03	20	82	2	GO:0061665
GeneOntologyMolecularFunction	protein domain specific binding	WBP1 NCOA6 EGR2 WASF2 KHDRBS2 DVL2 IST1 NFKBIZ PLSCR3 MED1	3.05e-03	875	82	10	GO:0019904
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	TRERF1 ZNF462 CCNT2 NCOA6 CRTC3 ELL2 ATF5 PTPRN EGR2 NFATC4 GLI1 ZMIZ2 SOX30 DVL2 LRP6 NFKBIZ MED1 TOX2 CDON SP7 TBX5	4.68e-08	1390	80	21	GO:0045944
GeneOntologyBiologicalProcess	brain development	ATP5PB SETD1A NCOR2 NCOA6 ATF5 EGR2 GLI1 USP9X LRP6 ROBO2 SIN3A MED1 CDON	2.46e-05	859	80	13	GO:0007420
GeneOntologyBiologicalProcess	head development	ATP5PB SETD1A NCOR2 NCOA6 ATF5 EGR2 GLI1 USP9X LRP6 ROBO2 SIN3A MED1 CDON	4.95e-05	919	80	13	GO:0060322
Domain	N-SET	SETD1A SETD1B	1.86e-05	2	81	2	PF11764
Domain	COMPASS_Set1_N-SET	SETD1A SETD1B	1.86e-05	2	81	2	IPR024657
Domain	N-SET	SETD1A SETD1B	1.86e-05	2	81	2	SM01291
Domain	Post-SET_dom	SETD1A SETD1B	2.14e-03	16	81	2	IPR003616
Domain	PostSET	SETD1A SETD1B	2.14e-03	16	81	2	SM00508
Domain	POST_SET	SETD1A SETD1B	2.14e-03	16	81	2	PS50868
Domain	Pentatricopeptide_repeat	DTNB POLRMT	4.43e-03	23	81	2	IPR002885
Domain	SANT_dom	TRERF1 NCOR2	5.64e-03	26	81	2	IPR017884
Domain	SANT	TRERF1 NCOR2	6.53e-03	28	81	2	PS51293
Domain	PH	IQSEC2 ARHGEF9 OBSCN TRIOBP PLEKHA7	7.20e-03	278	81	5	SM00233
Domain	PH_DOMAIN	IQSEC2 ARHGEF9 OBSCN TRIOBP PLEKHA7	7.31e-03	279	81	5	PS50003
Domain	PH_domain	IQSEC2 ARHGEF9 OBSCN TRIOBP PLEKHA7	7.41e-03	280	81	5	IPR001849
Pathway	WP_HEDGEHOG_SIGNALING_WP47	GLI1 PTCH2 SIN3A	3.95e-05	16	60	3	M39675
Pathway	REACTOME_MITOCHONDRIAL_BIOGENESIS	ATP5PB NCOA6 CRTC3 POLRMT MED1	5.36e-05	96	60	5	M26973
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NCOR2 SIN3A MED1	5.72e-05	18	60	3	MM15034
Pathway	REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS	NCOA6 CRTC3 POLRMT MED1	8.60e-05	55	60	4	M27145
Pathway	WP_HEDGEHOG_SIGNALING_PATHWAY	GLI1 PTCH2 SIN3A	1.07e-04	22	60	3	MM15924
Pathway	REACTOME_CYTOPROTECTION_BY_HMOX1	NCOR2 NCOA6 SIN3A MED1	1.21e-04	60	60	4	M41830
Pathway	BIOCARTA_CARM_ER_PATHWAY	NCOR2 MED1 SPEN	1.78e-04	26	60	3	M2499
Pathway	REACTOME_GENE_EXPRESSION_TRANSCRIPTION	CCNT2 CASC3 SETD1A NCOR2 ELL2 SETD1B USP9X PIP4P1 POLRMT SIN3A MED1 HDAC7 TBX5	2.97e-04	1022	60	13	MM15436
Pathway	REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION	GLI1 PTCH2	3.69e-04	7	60	2	M27501
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	NCOR2 NCOA6 EGR2 MED1	4.44e-04	84	60	4	M1008
Pathway	KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR	PTCH2 CDON	6.29e-04	9	60	2	M47893
Pathway	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER	CCNT2 NCOR2 USP9X	6.96e-04	41	60	3	MM14876
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	SETD1A NCOA6 SETD1B	7.48e-04	42	60	3	M48018
Pathway	WP_HEDGEHOG_SIGNALING_WP4249	GLI1 PTCH2 CDON	8.01e-04	43	60	3	M39706
Pathway	REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION	SETD1A SETD1B SIN3A	8.57e-04	44	60	3	MM15527
Pathway	REACTOME_HEME_SIGNALING	NCOA6 CRTC3 MED1	1.18e-03	49	60	3	M41832
Pathway	REACTOME_ADIPOGENESIS	NCOR2 NCOA6 EGR2 MED1	1.22e-03	110	60	4	M48259
Pathway	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER	CCNT2 NCOR2 USP9X	1.32e-03	51	60	3	M665
Pathway	REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME	NCOR2 SIN3A	1.35e-03	13	60	2	M29766
Pathway	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	CCNT2 SETD1A NCOR2 SETD1B USP9X PIP4P1 SIN3A MED1 HDAC7 TBX5	1.37e-03	768	60	10	MM14851
Pathway	REACTOME_CYTOPROTECTION_BY_HMOX1	NCOR2 SIN3A MED1	1.40e-03	52	60	3	MM15684
Pathway	KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY	GLI1 PTCH2	1.57e-03	14	60	2	M47414
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NCOR2 NCOA6 SIN3A MED1	1.59e-03	118	60	4	M27316
Pathway	KEGG_BASAL_CELL_CARCINOMA	GLI1 DVL2 PTCH2	1.64e-03	55	60	3	M17807
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	CCNT2 CASC3 SETD1A NCOR2 ELL2 SETD1B RBFOX3 USP9X PIP4P1 SIN3A MED1 HDAC7 SP7 TBX5	1.70e-03	1387	60	14	M734
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TRERF1 WBP1 SETD1A NCOR2 NCOA6 CRTC3 ZNF469 ATF5 EGR2 NFATC4 BICRA ZMIZ2 PIP4P1 SIN3A SPEN PLEKHA7 VPS37B RNF11	9.07e-18	430	82	18	35044719
Pubmed	Human transcription factor protein interaction networks.	TRERF1 ATP5PB ZNF462 PRR12 SETD1A NCOR2 NCOA6 GSE1 NFATC4 BICRA PRRC2C USP9X ZMIZ2 PIP4P1 LRP6 PROSER1 SIN3A NDUFA8 SPEN CCDC86 SP7	1.11e-11	1429	82	21	35140242
Pubmed	Interaction network of human early embryonic transcription factors.	TRERF1 ZNF462 PRR12 SETD1A NCOR2 NCOA6 GSE1 EGR2 BICRA ZMIZ2 PROSER1 SPEN	4.07e-11	351	82	12	38297188
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	PRR12 NCOR2 GSE1 BICRA ZMIZ2 CCDC120 PROSER1 VPS37B	3.00e-09	152	82	8	38360978
Pubmed	Control of developmentally primed erythroid genes by combinatorial co-repressor actions.	NCOR2 GSE1 SIN3A CBFA2T3 SPEN	8.76e-09	30	82	5	26593974
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TRERF1 CCNT2 NCOR2 MYOF NCOA6 GSE1 KDM5C TJAP1 SIN3A MED1 SPEN CCDC86 HDAC7	3.23e-08	774	82	13	15302935
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	PRR12 NCOR2 NCOA6 GSE1 MED1 SPEN	4.66e-08	83	82	6	28794006
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	NCOR2 GSE1 NFATC4 PRRC2C GLI1 KDM5C WASF2 DVL2 POLRMT SIN3A CBFA2T3 SPEN CCDC86	1.05e-07	857	82	13	25609649
Pubmed	Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression.	NCOR2 SIN3A HDAC7	1.26e-07	5	82	3	10640276
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	PRR12 NCOR2 CRTC3 GSE1 TMEM209 CCDC120 PLEKHA7	2.43e-07	180	82	7	35198878
Pubmed	Deficiency of Wdr60 and Wdr34 cause distinct neural tube malformation phenotypes in early embryos.	SETD1A GLI1 PTCH2 LRP6	4.12e-07	26	82	4	37228654
Pubmed	The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies.	NCOR2 SIN3A CBFA2T3	4.39e-07	7	82	3	12242670
Pubmed	A distinct Smoothened mutation causes severe cerebellar developmental defects and medulloblastoma in a novel transgenic mouse model.	RBFOX3 GLI1 PTCH2	7.01e-07	8	82	3	22869526
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	NCOR2 NCOA6 GSE1 MED1 SPEN	1.19e-06	78	82	5	28611094
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	PRR12 NCOR2 NCOA6 CRTC3 GSE1 PRRC2C GLI1 TMEM209 POLRMT	1.35e-06	457	82	9	32344865
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PRR12 SETD1A NCOR2 MYOF NCOA6 SETD1B BICRA GLI1 ZMIZ2 OBSCN POLRMT SPEN HDAC7	1.83e-06	1105	82	13	35748872
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TRERF1 ZNF462 CASC3 NCOR2 PRRC2C USP9X WASF2 IQSEC2 CNKSR3 DVL2 TRIOBP TJAP1	2.65e-06	963	82	12	28671696
Pubmed	Lhx2 is a progenitor-intrinsic modulator of Sonic Hedgehog signaling during early retinal neurogenesis.	GLI1 PTCH2 CDON	2.74e-06	12	82	3	36459481
Pubmed	Wnt1 Lineage Specific Deletion of Gpr161 Results in Embryonic Midbrain Malformation and Failure of Craniofacial Skeletal Development.	GLI1 DVL2 LRP6	3.55e-06	13	82	3	34887903
Pubmed	Ptch2/Gas1 and Ptch1/Boc differentially regulate Hedgehog signalling in murine primordial germ cell migration.	GLI1 PTCH2 CDON	3.55e-06	13	82	3	32332736
Pubmed	Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes.	TRERF1 NCOR2 GSE1 SIN3A	3.97e-06	45	82	4	21258344
Pubmed	Comparative sequence and x-inactivation analyses of a domain of escape in human xp11.2 and the conserved segment in mouse.	KDM5C IQSEC2	5.49e-06	2	82	2	15197169
Pubmed	The H3K4 methyltransferase Setd1a is first required at the epiblast stage, whereas Setd1b becomes essential after gastrulation.	SETD1A SETD1B	5.49e-06	2	82	2	24550110
Pubmed	Myoferlin Regulates Wnt/β-Catenin Signaling-Mediated Skeletal Muscle Development by Stabilizing Dishevelled-2 Against Autophagy.	MYOF DVL2	5.49e-06	2	82	2	31623157
Pubmed	In Vivo and In Vitro Characterization of the RNA Binding Capacity of SETD1A (KMT2F).	SETD1A SETD1B	5.49e-06	2	82	2	38003223
Pubmed	Downregulation of NFAT3 Due to Lack of T-Box Transcription Factor TBX5 Is Crucial for Cytokine Expression in T Cells.	NFATC4 TBX5	5.49e-06	2	82	2	29180489
Pubmed	Zinc finger proteins: what we know and what we would like to know.	EGR2 GLI1	5.49e-06	2	82	2	1768617
Pubmed	Peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP) but not PPAR-interacting protein (PRIP) is required for nuclear translocation of constitutive androstane receptor in mouse liver.	NCOA6 MED1	5.49e-06	2	82	2	16828057
Pubmed	A predictive model of bifunctional transcription factor signaling during embryonic tissue patterning.	GLI1 PTCH2 CDON	5.63e-06	15	82	3	25458012
Pubmed	The functional interactome landscape of the human histone deacetylase family.	TRERF1 NCOR2 GSE1 USP9X MDM1 SIN3A HDAC7	5.68e-06	289	82	7	23752268
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	ATP5PB ZNF462 NCOR2 PIP4P1 PROSER1 SIN3A MED1 TBX5	5.91e-06	411	82	8	35182466
Pubmed	Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions.	TRERF1 NCOR2 WASF2 SPEN RNF11	6.49e-06	110	82	5	37219487
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TRERF1 ZNF462 PRR12 NCOR2 GSE1 ZMIZ2 DVL2 POLRMT	6.68e-06	418	82	8	34709266
Pubmed	SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53.	SETD1A NCOA6 SETD1B	6.92e-06	16	82	3	23870121
Pubmed	H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.	SETD1A NCOA6 SETD1B	6.92e-06	16	82	3	24368734
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TRERF1 PRR12 CCNT2 NCOR2 NCOA6 GSE1 BICRA PRRC2C ZMIZ2 SIN3A MED1 SPEN	1.05e-05	1103	82	12	34189442
Pubmed	Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.	SETD1A NCOA6 SETD1B	1.40e-05	20	82	3	29785026
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	NCOR2 NCOA6 MED1	1.40e-05	20	82	3	11877444
Pubmed	FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis.	NCOR2 SETD1B SIN3A	1.40e-05	20	82	3	27773593
Pubmed	Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.	NCOR2 NCOA6 MED1	1.63e-05	21	82	3	19596656
Pubmed	WDR82, a key epigenetics-related factor, plays a crucial role in normal early embryonic development in mice.	SETD1A SETD1B	1.64e-05	3	82	2	21123813
Pubmed	Molecular insight into the SETD1A/B N-terminal region and its interaction with WDR82.	SETD1A SETD1B	1.64e-05	3	82	2	37030068
Pubmed	Smooth muscle fascicular reorientation is required for esophageal morphogenesis and dependent on Cdo.	GLI1 CDON	1.64e-05	3	82	2	23569214
Pubmed	Structural insights into the recruitment of SMRT by the corepressor SHARP under phosphorylative regulation.	NCOR2 SPEN	1.64e-05	3	82	2	24268649
Pubmed	Xp11.2 microduplications including IQSEC2, TSPYL2 and KDM5C genes in patients with neurodevelopmental disorders.	KDM5C IQSEC2	1.64e-05	3	82	2	26059843
Pubmed	The glucocorticoid receptor recruits the COMPASS complex to regulate inflammatory transcription at macrophage enhancers.	SETD1A SETD1B	1.64e-05	3	82	2	33567280
Pubmed	Structural basis for activity regulation of MLL family methyltransferases.	SETD1A NCOA6 SETD1B	1.88e-05	22	82	3	26886794
Pubmed	The G protein-coupled receptor Gpr161 regulates forelimb formation, limb patterning and skeletal morphogenesis in a primary cilium-dependent manner.	GLI1 SP7 TBX5	2.16e-05	23	82	3	29222391
Pubmed	FOXC1 and FOXC2 regulate growth plate chondrocyte maturation towards hypertrophy in the embryonic mouse limb skeleton.	GLI1 PTCH2 SP7	2.47e-05	24	82	3	39012257
Pubmed	Shh signaling within the dental epithelium is necessary for cell proliferation, growth and polarization.	AMBN GLI1 PTCH2	2.47e-05	24	82	3	12403705
Pubmed	T-box3 is a ciliary protein and regulates stability of the Gli3 transcription factor to control digit number.	GLI1 PTCH2 TBX5	2.80e-05	25	82	3	27046536
Pubmed	Transcriptional coactivator PRIP, the peroxisome proliferator-activated receptor gamma (PPARgamma)-interacting protein, is required for PPARgamma-mediated adipogenesis.	NCOA6 MED1	3.28e-05	4	82	2	12754253
Pubmed	Interaction of the Epstein-Barr virus mRNA export factor EB2 with human Spen proteins SHARP, OTT1, and a novel member of the family, OTT3, links Spen proteins with splicing regulation and mRNA export.	NCOR2 SPEN	3.28e-05	4	82	2	16129689
Pubmed	Wnt3a-mediated formation of phosphatidylinositol 4,5-bisphosphate regulates LRP6 phosphorylation.	DVL2 LRP6	3.28e-05	4	82	2	18772438
Pubmed	The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling.	DVL2 LRP6	3.28e-05	4	82	2	18838381
Pubmed	Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions.	DVL2 LRP6	3.28e-05	4	82	2	18077588
Pubmed	Protective neuronal induction of ATF5 in endoplasmic reticulum stress induced by status epilepticus.	ATF5 RBFOX3	3.28e-05	4	82	2	23518711
Pubmed	Wdpcp regulates cellular proliferation and differentiation in the developing limb via hedgehog signaling.	GLI1 SP7	3.28e-05	4	82	2	34225660
Pubmed	Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor.	NCOR2 SPEN	3.28e-05	4	82	2	15062576
Pubmed	Role of the histone deacetylase complex in acute promyelocytic leukaemia.	NCOR2 SIN3A	3.28e-05	4	82	2	9486654
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	NCOA6 SETD1B KDM5C SIN3A HDAC7	3.63e-05	157	82	5	30186101
Pubmed	Loss of BAF (mSWI/SNF) chromatin-remodeling ATPase Brg1 causes multiple malformations of cortical development in mice.	RBFOX3 ROBO2 CDON	3.97e-05	28	82	3	35666215
Pubmed	Temporospatial sonic hedgehog signalling is essential for neural crest-dependent patterning of the intrinsic tongue musculature.	GLI1 PTCH2 CDON	3.97e-05	28	82	3	31719045
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	NCOR2 ATF5 NFATC4 GLI1 KDM5C NFKBIZ SIN3A MED1 SPEN SP7	4.10e-05	877	82	10	20211142
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TRERF1 PRR12 NCOA6 GSE1 SIN3A MED1	4.25e-05	268	82	6	33640491
Pubmed	A Retinoic Acid-Hedgehog Cascade Coordinates Mesoderm-Inducing Signals and Endoderm Competence during Lung Specification.	GLI1 PTCH2 TBX5	4.42e-05	29	82	3	27320915
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	PRR12 CASC3 MYOF WASF2 ARHGEF9 POLRMT IST1 TRIOBP MED1 NDUFA8 SPEN PLEKHA7 CCDC86	4.63e-05	1497	82	13	31527615
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETD1B GSE1 PRRC2C ARHGEF9 IST1 OGFOD1 SPEN	5.10e-05	407	82	7	12693553
Pubmed	Ifg, Gli, Mdm1, Mdm2, and Mdm3: candidate genes for the mouse pg locus.	GLI1 MDM1	5.47e-05	5	82	2	7849395
Pubmed	Biochemical reconstitution and phylogenetic comparison of human SET1 family core complexes involved in histone methylation.	SETD1A SETD1B	5.47e-05	5	82	2	25561738
Pubmed	Reciprocal actions of ATF5 and Shh in proliferation of cerebellar granule neuron progenitor cells.	ATF5 RBFOX3	5.47e-05	5	82	2	22095825
Pubmed	Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6.	NCOR2 SIN3A	5.47e-05	5	82	2	9765306
Pubmed	Expression of Sonic Hedgehog and pathway components in the embryonic mouse head: anatomical relationships between regulators of positive and negative feedback.	GLI1 PTCH2	5.47e-05	5	82	2	34353359
Pubmed	Helicobacter pylori-induced activation of beta-catenin involves low density lipoprotein receptor-related protein 6 and Dishevelled.	DVL2 LRP6	5.47e-05	5	82	2	20137080
Pubmed	Mint represses transactivation of the type II collagen gene enhancer through interaction with alpha A-crystallin-binding protein 1.	NCOR2 SPEN	5.47e-05	5	82	2	15778499
Pubmed	RUNX1 regulates corepressor interactions of PU.1.	SIN3A CBFA2T3	5.47e-05	5	82	2	21518930
Pubmed	Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation.	NCOA6 MED1	5.47e-05	5	82	2	11912212
Pubmed	Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells.	NCOR2 SIN3A	5.47e-05	5	82	2	15729358
Pubmed	A Shh coreceptor Cdo is required for efficient cardiomyogenesis of pluripotent stem cells.	GLI1 CDON	5.47e-05	5	82	2	26906632
Pubmed	Expression pattern of the thrombopoietin receptor (Mpl) in the murine central nervous system.	THPO RBFOX3	5.47e-05	5	82	2	20667107
Pubmed	Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver.	NCOA6 MED1	8.19e-05	6	82	2	15150259
Pubmed	Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma.	GLI1 PTCH2	8.19e-05	6	82	2	19487286
Pubmed	CRM1 mediates nuclear export of HDAC7 independently of HDAC7 phosphorylation and association with 14-3-3s.	NCOR2 HDAC7	8.19e-05	6	82	2	16956611
Pubmed	Expression Profiling and Functional Analysis of Candidate Col10a1 Regulators Identified by the TRAP Program.	EGR2 TBX5	8.19e-05	6	82	2	34276786
Pubmed	Development gone awry: congenital heart disease.	DVL2 TBX5	8.19e-05	6	82	2	14976138
Pubmed	The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3.	NCOR2 SPEN	8.19e-05	6	82	2	25915022
Pubmed	Gli1 Regulates the Postnatal Acquisition of Peripheral Nerve Architecture.	EGR2 GLI1	8.19e-05	6	82	2	34772739
Pubmed	PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors.	NCOR2 SIN3A	8.19e-05	6	82	2	11259580
Pubmed	Nuclear factor of activated T cells (NFAT) proteins repress canonical Wnt signaling via its interaction with Dishevelled (Dvl) protein and participate in regulating neural progenitor cell proliferation and differentiation.	NFATC4 DVL2	8.19e-05	6	82	2	21880741
Pubmed	Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors.	LRP6 TBX5	8.19e-05	6	82	2	12626757
Pubmed	Boc modifies the spectrum of holoprosencephaly in the absence of Gas1 function.	GLI1 CDON	8.19e-05	6	82	2	25063195
Pubmed	Epsin is required for Dishevelled stability and Wnt signalling activation in colon cancer development.	DVL2 LRP6	8.19e-05	6	82	2	25871009
Pubmed	Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway.	NCOR2 SIN3A	8.19e-05	6	82	2	10640275
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	SETD1A SETD1B USP9X DVL2 TMEM209 POLRMT MED1	8.31e-05	440	82	7	34244565
Pubmed	CXXC finger protein 1 contains redundant functional domains that support embryonic stem cell cytosine methylation, histone methylation, and differentiation.	SETD1A SETD1B	1.14e-04	7	82	2	19433449
Pubmed	Altered bone growth dynamics prefigure craniosynostosis in a zebrafish model of Saethre-Chotzen syndrome.	GLI1 SP7	1.14e-04	7	82	2	30375332
Pubmed	Ocular abnormalities in mice lacking the immunoglobulin superfamily member Cdo.	CDON TBX5	1.14e-04	7	82	2	19754878
Pubmed	A mutant with bilateral whisker to barrel inputs unveils somatosensory mapping rules in the cerebral cortex.	RBFOX3 EGR2	1.14e-04	7	82	2	28350297
Pubmed	The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.	NCOR2 SPEN	1.14e-04	7	82	2	11867749
Pubmed	Osterix is dispensable for the development of the mouse olfactory bulb.	RBFOX3 SP7	1.14e-04	7	82	2	27449610
Interaction	EGR2 interactions	TRERF1 ZNF462 PRR12 NCOR2 NCOA6 EGR2 BICRA ZMIZ2 PROSER1	3.18e-08	171	82	9	int:EGR2
Interaction	RUNX1T1 interactions	NCOR2 GSE1 DVL2 SIN3A PLSCR3 CBFA2T3 SPEN TBX5	4.80e-08	127	82	8	int:RUNX1T1
Interaction	KDM6A interactions	SETD1A NCOA6 SETD1B EGR2 KDM5C PROSER1 SP7 TBX5	3.15e-07	162	82	8	int:KDM6A
Interaction	SP7 interactions	TRERF1 PRR12 NCOR2 NCOA6 GSE1 BICRA ZMIZ2 PROSER1 SIN3A SP7	4.32e-07	304	82	10	int:SP7
Interaction	EYA4 interactions	PRR12 NCOR2 GSE1 BICRA ZMIZ2 CCDC120 PROSER1 VPS37B SP7	6.33e-07	243	82	9	int:EYA4
Interaction	HNF4A interactions	ZNF462 PRR12 SETD1A NCOR2 NCOA6 GSE1 BICRA MED1 SPEN	1.77e-06	275	82	9	int:HNF4A
Interaction	NCOA6 interactions	SETD1A NCOR2 NCOA6 SETD1B EGR2 MED1 SP7	2.09e-06	145	82	7	int:NCOA6
Interaction	TLE3 interactions	TRERF1 PRR12 NCOR2 CRTC3 GSE1 EGR2 ZMIZ2 PROSER1 SPEN SP7	2.94e-06	376	82	10	int:TLE3
Interaction	KDM1A interactions	TRERF1 ATP5PB ZNF462 PRR12 NCOR2 GSE1 USP9X DVL2 POLRMT SIN3A NDUFA8 CBFA2T3 VPS37B SP7 TBX5	5.19e-06	941	82	15	int:KDM1A
Interaction	NUP35 interactions	PRR12 NCOR2 NCOA6 CRTC3 GSE1 PRRC2C GLI1 TMEM209 POLRMT TBX5	8.47e-06	424	82	10	int:NUP35
Interaction	CRX interactions	TRERF1 ZNF462 PRR12 NCOR2 BICRA ZMIZ2 PROSER1 SPEN	9.09e-06	254	82	8	int:CRX
Interaction	GUSBP5 interactions	NCOR2 GSE1 KDM5C DVL2 SPEN	1.36e-05	75	82	5	int:GUSBP5
Interaction	PAX9 interactions	PRR12 NCOR2 NCOA6 GSE1 ZMIZ2 PROSER1	1.50e-05	130	82	6	int:PAX9
Interaction	NCOR1 interactions	NCOR2 EGR2 KDM5C SIN3A CBFA2T3 SPEN HDAC7 TRIM52 SP7	1.66e-05	363	82	9	int:NCOR1
Interaction	FEV interactions	ZNF462 PRR12 SETD1A NCOR2 NCOA6 GSE1 BICRA	1.90e-05	203	82	7	int:FEV
Interaction	YAP1 interactions	TRERF1 WBP1 SETD1A NCOA6 CRTC3 PRRC2C GLI1 USP9X PIP4P1 TRIOBP CCDC120 SIN3A MED1 SPEN RNF11	3.12e-05	1095	82	15	int:YAP1
Interaction	RERE interactions	SETD1A SETD1B EGR2 CCDC120 SP7	3.87e-05	93	82	5	int:RERE
Interaction	NFIX interactions	PRR12 SETD1A NCOR2 GSE1 BICRA SPEN SP7	3.89e-05	227	82	7	int:NFIX
Interaction	SHH interactions	PTCH2 SIN3A CDON	5.07e-05	18	82	3	int:SHH
Interaction	SOX5 interactions	NCOR2 GSE1 EGR2 PRRC2C PROSER1 SP7	5.20e-05	162	82	6	int:SOX5
Interaction	IRF2BP2 interactions	NCOR2 SIN3A CBFA2T3 SPEN SP7	8.64e-05	110	82	5	int:IRF2BP2
Interaction	ZMYND10 interactions	NUTM1 WBP1 TBX5	9.46e-05	22	82	3	int:ZMYND10
Interaction	TBR1 interactions	PRR12 NCOR2 GSE1 PROSER1 SP7	9.81e-05	113	82	5	int:TBR1
Interaction	ITCH interactions	TRERF1 WBP1 GLI1 USP9X DVL2 LRP6 SPEN RNF11	1.00e-04	356	82	8	int:ITCH
Interaction	NCOR2 interactions	NCOR2 NCOA6 EGR2 SIN3A SPEN HDAC7 SP7	1.01e-04	264	82	7	int:NCOR2
Interaction	TBXT interactions	PRR12 NCOR2 NCOA6 GSE1 SPEN	1.11e-04	116	82	5	int:TBXT
Interaction	FLI1 interactions	EGR2 USP9X SOX30 SP7	1.19e-04	62	82	4	int:FLI1
Interaction	HNF1B interactions	PRR12 NCOR2 GSE1 BICRA PROSER1 SP7	1.25e-04	190	82	6	int:HNF1B
Interaction	EP300 interactions	TRERF1 NUTM1 CASC3 SETD1A NCOR2 NCOA6 ZNF469 ATF5 THPO EGR2 USP9X DVL2 SIN3A MED1 HDAC7 SP7	1.43e-04	1401	82	16	int:EP300
Interaction	RBBP5 interactions	CCNT2 SETD1A NCOA6 SETD1B EGR2 SIN3A SPEN	1.69e-04	287	82	7	int:RBBP5
Interaction	NR1H2 interactions	NCOR2 NCOA6 ROBO2 MED1	1.70e-04	68	82	4	int:NR1H2
Interaction	TLX3 interactions	PRR12 NCOR2 NCOA6 GSE1 ZMIZ2 PROSER1 TOX2	1.84e-04	291	82	7	int:TLX3
Interaction	HCFC1 interactions	SETD1A NCOA6 SETD1B EGR2 PRRC2C SIN3A TBX5	1.92e-04	293	82	7	int:HCFC1
Interaction	HDAC4 interactions	PRR12 NCOR2 SETD1B RBFOX3 EGR2 PRRC2C USP9X WASF2 SIN3A PLEKHA7 HDAC7	2.07e-04	744	82	11	int:HDAC4
Interaction	KMT2C interactions	SETD1A NCOA6 SETD1B EGR2 SP7	2.18e-04	134	82	5	int:KMT2C
Interaction	NUP43 interactions	ZNF462 CCNT2 SETD1A NCOR2 NCOA6 SETD1B GSE1 PRRC2C KDM5C SPEN	2.20e-04	625	82	10	int:NUP43
Interaction	GATA4 interactions	ATP5PB ZNF462 NCOR2 NFATC4 PIP4P1 PROSER1 MED1 TBX5	2.67e-04	411	82	8	int:GATA4
Interaction	PROSER1 interactions	EGR2 PROSER1 SP7	2.69e-04	31	82	3	int:PROSER1
Interaction	FOXQ1 interactions	ATP5PB NCOR2 GSE1 POLRMT CCDC86	2.76e-04	141	82	5	int:FOXQ1
Interaction	ERG interactions	PRR12 NCOR2 NCOA6 GSE1 BICRA USP9X	2.98e-04	223	82	6	int:ERG
Interaction	TRERF1 interactions	TRERF1 EGR2 SP7	3.24e-04	33	82	3	int:TRERF1
Interaction	TRB interactions	NCOA6 DVL2	3.39e-04	7	82	2	int:TRB
Interaction	BCL6 interactions	ATP5PB NCOR2 ARHGEF9 DVL2 SIN3A HDAC7	3.44e-04	229	82	6	int:BCL6
Interaction	DTX2 interactions	PRR12 NCOR2 CRTC3 GSE1 TMEM209 CCDC120 PLEKHA7	3.94e-04	330	82	7	int:DTX2
Interaction	PBX1 interactions	USP9X CCDC120 SP7 TBX5	4.01e-04	85	82	4	int:PBX1
Interaction	SOX6 interactions	NCOR2 GSE1 PRRC2C ZMIZ2 PROSER1	4.53e-04	157	82	5	int:SOX6
Interaction	CEBPA interactions	TRERF1 PRR12 CCNT2 NCOR2 NCOA6 ATF5 GSE1 NFATC4 BICRA PRRC2C ZMIZ2 SIN3A MED1 SPEN	4.63e-04	1245	82	14	int:CEBPA
Interaction	HDAC1 interactions	TRERF1 NCOR2 GSE1 FOLH1 GLI1 KDM5C ZMIZ2 DVL2 POLRMT SIN3A CBFA2T3 SPEN HDAC7	5.07e-04	1108	82	13	int:HDAC1
Interaction	TRIM33 interactions	EGR2 USP9X KDM5C DVL2 CBFA2T3 TRIM52 SP7 TBX5	5.10e-04	453	82	8	int:TRIM33
Interaction	PRMT2 interactions	SETD1A NCOA6 SETD1B IQSEC2	5.20e-04	91	82	4	int:PRMT2
Interaction	NFKBIL1 interactions	SETD1A USP9X DVL2 SPEN	5.65e-04	93	82	4	int:NFKBIL1
Interaction	ZNF608 interactions	SETD1A SETD1B EGR2 SP7	5.65e-04	93	82	4	int:ZNF608
GeneFamily	X-linked mental retardation\|Angiotensin receptors	USP9X KDM5C IQSEC2	5.91e-04	53	56	3	103
Coexpression	GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_UP	DDR1 SETD1B GSE1 ERN1 DTNB GLI1 PIP4P1	3.18e-06	200	82	7	M9342
Coexpression	GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	SETD1A NCOR2 MDM1 SIN3A SPEN TRIM52	4.06e-06	134	82	6	M430
Coexpression	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN	SETD1A CRTC3 BICRA WASF2 OGFOD1 PLEKHA7	9.38e-06	155	82	6	M8944
Coexpression	GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP	PTPRN EGR2 CASKIN2 IST1 NFKBIZ VPS37B	3.85e-05	199	82	6	M7885
Coexpression	GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_DN	EGR2 NFATC4 CASKIN2 GLI1 CCDC86 HDAC7	3.96e-05	200	82	6	M7070
Coexpression	GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP	CCNT2 NCOR2 PTPRN LRP6 MED1 CBFA2T3	3.96e-05	200	82	6	M4884
Drug	Sulconazole nitrate [61318-91-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A	NCOR2 MYOF NFATC4 DTNB PTCH2 TJAP1 TBX5	5.03e-06	189	81	7	3373_UP
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A	MYOF ATF5 THPO ARHGEF9 DVL2 LRP6 PLSCR3	5.58e-06	192	81	7	2703_DN
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A	GPR137 SETD1A AMPD3 IQSEC2 LRP6 TJAP1 SPEN	5.77e-06	193	81	7	2209_DN
Drug	Tridihexethyl chloride; Up 200; 11.4uM; MCF7; HT_HG-U133A	GPR137 SETD1A BICRA ZMIZ2 HDAC7 CDON TBX5	5.97e-06	194	81	7	3526_UP
Drug	GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A	SETD1A ATF5 NFATC4 CASKIN2 PRRC2C ZMIZ2 TRIOBP	6.39e-06	196	81	7	6559_UP
Drug	Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; PC3; HT_HG-U133A	GPR137 MYOF AMPD3 CASKIN2 KDM5C MDM1 ARHGEF9	6.61e-06	197	81	7	2072_DN
Drug	Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A	GPR137 AMPD3 CASKIN2 ZMIZ2 IQSEC2 LRP6 HDAC7	7.06e-06	199	81	7	4986_UP
Drug	rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A	NCOR2 MYOF IQSEC2 KHDRBS2 ARHGEF9 DVL2 CDON	7.06e-06	199	81	7	2693_DN
Drug	LY 294002; Down 200; 0.1uM; HL60; HT_HG-U133A	SETD1A NCOR2 MYOF THPO KHDRBS2 LRP6 CDON	7.06e-06	199	81	7	2676_DN
Drug	4-(4-(2,3-dihydrobenzo(1,4)dioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide	DVL2 LRP6	3.74e-05	3	81	2	ctd:C493177
Drug	scriptaid; Down 200; 10uM; PC3; HT_HG-U133A	CCNT2 MYOF ARHGEF9 TRIOBP MED1 HDAC7	4.74e-05	182	81	6	6896_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A	GPR137 SETD1A CASKIN2 ZMIZ2 TMEM209 TJAP1	6.57e-05	193	81	6	4338_DN
Drug	Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A	SETD1A MDM1 ARHGEF9 LRP6 PLSCR3 MED1	6.76e-05	194	81	6	7468_DN
Drug	Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	AMPD3 KDM5C ZMIZ2 SOX30 DVL2 TBX5	6.76e-05	194	81	6	3977_DN
Drug	CP-690334-01 [459212-38-5]; Up 200; 10uM; MCF7; HT_HG-U133A	GPR137 SETD1B DTNB SOX30 TJAP1 CDON	6.76e-05	194	81	6	3906_UP
Drug	2-Chloropyrazine [14508-49-7]; Down 200; 35uM; MCF7; HT_HG-U133A	CCNT2 AMPD3 CASKIN2 KDM5C ARHGEF9 TRIOBP	6.76e-05	194	81	6	3570_DN
Drug	Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	GPR137 SETD1A NCOR2 DVL2 HDAC7 TBX5	6.96e-05	195	81	6	5265_UP
Drug	Cinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A	GPR137 NFATC4 ZMIZ2 TMEM209 CDON TBX5	6.96e-05	195	81	6	4107_UP
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A	GPR137 NCOR2 SETD1B ZMIZ2 IQSEC2 DVL2	6.96e-05	195	81	6	3714_DN
Drug	Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A	GPR137 CCNT2 ZMIZ2 IQSEC2 TJAP1 HDAC7	6.96e-05	195	81	6	4399_DN
Drug	Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A	NCOR2 AMPD3 KHDRBS2 PLSCR3 CDON TBX5	6.96e-05	195	81	6	4124_UP
Drug	Finasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	GPR137 AMPD3 NFATC4 SOX30 TMEM209 TJAP1	7.16e-05	196	81	6	6062_UP
Drug	Sulpiride [15676-16-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CCNT2 MYOF ZMIZ2 DVL2 TJAP1 HDAC7	7.16e-05	196	81	6	4389_DN
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A	SETD1A MYOF AMPD3 TMEM209 TJAP1 PLSCR3	7.16e-05	196	81	6	2318_DN
Drug	Hydroflumethiazide [135-09-1]; Up 200; 12uM; MCF7; HT_HG-U133A	GPR137 MYOF IQSEC2 TJAP1 PLSCR3 CDON	7.16e-05	196	81	6	1687_UP
Drug	Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A	GPR137 MYOF DTNB ZMIZ2 IQSEC2 PLSCR3	7.36e-05	197	81	6	2888_UP
Drug	Quinic acid [86-68-0]; Up 200; 19.6uM; MCF7; HT_HG-U133A	GPR137 SETD1A ERN1 NFATC4 TMEM209 PLSCR3	7.36e-05	197	81	6	3540_UP
Drug	Benzamil hydrochloride [2898-76-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A	GPR137 AMPD3 SETD1B ERN1 NFATC4 TBX5	7.36e-05	197	81	6	4760_UP
Drug	Spaglumic acid [4910-46-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A	SETD1A CASKIN2 ARHGEF9 DVL2 TMEM209 PLSCR3	7.36e-05	197	81	6	7465_DN
Drug	NS-398; Down 200; 10uM; MCF7; HT_HG-U133A	KDM5C ZMIZ2 IQSEC2 DVL2 TRIOBP PLSCR3	7.36e-05	197	81	6	6897_DN
Drug	estradiol, USP; Up 200; 0.1uM; PC3; HT_HG-U133A	GPR137 CCNT2 ZMIZ2 ARHGEF9 TMEM209 TJAP1	7.57e-05	198	81	6	1208_UP
Drug	Nafcillin sodium salt monohydrate [7177-50-6]; Down 200; 8.8uM; HL60; HT_HG-U133A	GPR137 THPO ZMIZ2 KHDRBS2 LRP6 HDAC7	7.57e-05	198	81	6	2983_DN
Drug	0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A	GPR137 CCNT2 NCOR2 ZMIZ2 ARHGEF9 TJAP1	7.57e-05	198	81	6	7391_UP
Drug	Famotidine [76824-35-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	GPR137 CCNT2 ERN1 MED1 CDON TBX5	7.57e-05	198	81	6	1529_UP
Drug	Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; PC3; HT_HG-U133A	MYOF ZMIZ2 ARHGEF9 MED1 SPEN HDAC7	7.57e-05	198	81	6	1825_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A	GPR137 SETD1A NCOR2 MYOF KHDRBS2 TJAP1	7.78e-05	199	81	6	2683_DN
Drug	Carbamazepine [298-46-4]; Up 200; 17uM; HL60; HT_HG-U133A	GPR137 MYOF KDM5C PLSCR3 HDAC7 CDON	7.78e-05	199	81	6	1847_UP
Drug	Palmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A	CCNT2 NCOR2 ERN1 DTNB LRP6 HDAC7	7.78e-05	199	81	6	4957_UP
Drug	Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; HL60; HT_HG-U133A	THPO ZMIZ2 IQSEC2 TMEM209 PLSCR3 HDAC7	8.00e-05	200	81	6	3014_DN
Drug	Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; PC3; HT_HG-U133A	GPR137 ATF5 BICRA KHDRBS2 DVL2 MED1	8.00e-05	200	81	6	7156_UP
Drug	Methamphetamine	NCOR2 AMPD3 THPO ERN1 EGR2 NFATC4 PRRC2C GLI1 WASF2 ZMIZ2 OBSCN IST1 TJAP1 VPS37B HDAC7	1.11e-04	1401	81	15	ctd:D008694
Drug	R)-3-pyrrolidinecarboxylic acid	THPO DTNB	1.86e-04	6	81	2	CID001501969
Drug	vinylene	ZNF462 NCOR2 EGR2 GLI1 ARHGEF9 SP7	2.42e-04	245	81	6	CID000006326
Drug	guvacoline	NUTM1 THPO	2.59e-04	7	81	2	CID000160492
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	MYOF ATF5 SETD1B CASKIN2 CBFA2T3	3.27e-04	167	81	5	3979_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	SETD1B CASKIN2 ARHGEF9 TRIOBP HDAC7	3.94e-04	174	81	5	3993_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA6 ATF5 SETD1B GSE1 CBFA2T3	3.94e-04	174	81	5	1659_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	GPR137 NCOR2 MYOF SETD1B CBFA2T3	4.16e-04	176	81	5	5976_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	MYOF ATF5 SETD1B MED1 HDAC7	4.27e-04	177	81	5	7047_DN
Drug	GANT 61	GLI1 KHDRBS2	4.43e-04	9	81	2	ctd:C551027
Drug	2-methoxy-5-nitrotropone	ELL2 DTNB	4.43e-04	9	81	2	CID000084563
Drug	NSC53670	EGR2 GLI1 KHDRBS2	5.17e-04	44	81	3	CID000243583
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	MYOF ARHGEF9 DVL2 TJAP1 HDAC7	5.22e-04	185	81	5	1022_UP
Drug	Flumethasone [2135-17-3]; Up 200; 9.8uM; HL60; HT_HG-U133A	NCOR2 DTNB ARHGEF9 PTCH2 PLSCR3	5.22e-04	185	81	5	2551_UP
Drug	Lithocholic acid [434-13-9]; Up 200; 10.6uM; HL60; HT_HG-U133A	MYOF ERN1 ARHGEF9 LRP6 TJAP1	5.48e-04	187	81	5	2571_UP
Drug	troglitazone; Down 200; 10uM; HL60; HT_HG-U133A	NCOR2 MYOF ZMIZ2 ARHGEF9 TJAP1	5.75e-04	189	81	5	2692_DN
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	GPR137 CCNT2 NCOR2 KDM5C ZMIZ2	5.89e-04	190	81	5	4340_DN
Drug	Fluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A	GPR137 AMPD3 PRRC2C TMEM209 LRP6	5.89e-04	190	81	5	4114_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; PC3; HT_HG-U133A	GPR137 NCOR2 CASKIN2 ZMIZ2 TJAP1	6.17e-04	192	81	5	4334_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	PRRC2C TMEM209 LRP6 TJAP1 PLSCR3	6.17e-04	192	81	5	3252_DN
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A	GPR137 SETD1A CASKIN2 DVL2 HDAC7	6.17e-04	192	81	5	4330_DN
Drug	Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A	GPR137 IQSEC2 DVL2 PLSCR3 HDAC7	6.32e-04	193	81	5	3627_DN
Drug	Levodopa [59-92-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A	GPR137 CCNT2 ZMIZ2 TJAP1 HDAC7	6.32e-04	193	81	5	4394_DN
Drug	Probenecid [57-66-9]; Down 200; 14uM; MCF7; HT_HG-U133A	AMPD3 ATF5 CASKIN2 BICRA TMEM209	6.32e-04	193	81	5	2825_DN
Drug	Hymecromone [90-33-5]; Down 200; 22.8uM; PC3; HT_HG-U133A	NCOR2 DTNB KDM5C IQSEC2 TJAP1	6.32e-04	193	81	5	4623_DN
Drug	5114445; Down 200; 10uM; MCF7; HT_HG-U133A_EA	ATF5 CASKIN2 PRRC2C TRIOBP SPEN	6.32e-04	193	81	5	901_DN
Drug	Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A	MYOF CASKIN2 BICRA TJAP1 HDAC7	6.32e-04	193	81	5	6646_DN
Drug	Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; PC3; HT_HG-U133A	MDM1 LRP6 TJAP1 PLSCR3 CDON	6.32e-04	193	81	5	6625_DN
Drug	Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A	CCNT2 MYOF AMPD3 CDON TBX5	6.32e-04	193	81	5	3296_UP
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A	GPR137 ATF5 CASKIN2 TMEM209 CCDC86	6.47e-04	194	81	5	5587_DN
Drug	Nystatine [1400-61-9]; Up 200; 4.4uM; PC3; HT_HG-U133A	GPR137 AMPD3 CASKIN2 ZMIZ2 IQSEC2	6.47e-04	194	81	5	4223_UP
Drug	Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; HL60; HT_HG-U133A	CCNT2 MYOF ARHGEF9 TMEM209 TJAP1	6.47e-04	194	81	5	2472_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A	GPR137 CASKIN2 KDM5C ZMIZ2 HDAC7	6.47e-04	194	81	5	4331_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	PRRC2C ZMIZ2 TMEM209 LRP6 MED1	6.47e-04	194	81	5	4361_DN
Drug	Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A	GPR137 MYOF CASKIN2 LRP6 CDON	6.47e-04	194	81	5	2221_DN
Drug	Etifenin [63245-28-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A	MYOF CASKIN2 TMEM209 PLSCR3 TBX5	6.47e-04	194	81	5	4117_UP
Drug	Tolbutamide [64-77-7]; Up 200; 14.8uM; PC3; HT_HG-U133A	THPO ERN1 DTNB KHDRBS2 TJAP1	6.62e-04	195	81	5	3804_UP
Drug	Sisomicin sulfate [53179-09-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A	DTNB ZMIZ2 DVL2 HDAC7 TBX5	6.62e-04	195	81	5	2853_UP
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; HL60; HT_HG-U133A	DVL2 TMEM209 LRP6 PLSCR3 MED1	6.62e-04	195	81	5	2409_DN
Drug	Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A	GPR137 SETD1A NCOR2 ZMIZ2 CDON	6.62e-04	195	81	5	3670_DN
Drug	Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A	GPR137 CCNT2 IQSEC2 KHDRBS2 MED1	6.62e-04	195	81	5	3455_UP
Drug	Clomiphene citrate (Z,E) [50-41-9]; Up 200; 6.6uM; MCF7; HT_HG-U133A	PTPRN ZMIZ2 IQSEC2 DVL2 HDAC7	6.62e-04	195	81	5	2624_UP
Drug	Ofloxacin [82419-36-1]; Up 200; 11uM; PC3; HT_HG-U133A	GPR137 NCOR2 CASKIN2 IQSEC2 TJAP1	6.62e-04	195	81	5	7372_UP
Drug	Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; HL60; HT_HG-U133A	CCNT2 ATF5 ZMIZ2 PLSCR3 HDAC7	6.62e-04	195	81	5	1273_UP
Drug	Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; MCF7; HT_HG-U133A	MYOF AMPD3 IQSEC2 LRP6 PLSCR3	6.62e-04	195	81	5	2653_UP
Drug	Amprolium hydrochloride [137-88-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A	NCOR2 ZMIZ2 IQSEC2 TMEM209 TJAP1	6.78e-04	196	81	5	1479_UP
Drug	Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; PC3; HT_HG-U133A	GPR137 MYOF ARHGEF9 TMEM209 LRP6	6.78e-04	196	81	5	7142_DN
Drug	Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A	GPR137 AMPD3 TMEM209 TJAP1 TBX5	6.78e-04	196	81	5	1515_UP
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A	MYOF AMPD3 ZMIZ2 IQSEC2 DVL2	6.78e-04	196	81	5	2314_DN
Drug	Quinic acid [86-68-0]; Down 200; 19.6uM; PC3; HT_HG-U133A	NCOR2 MYOF BICRA DVL2 CDON	6.78e-04	196	81	5	7317_DN
Drug	Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A	AMPD3 SETD1B KDM5C ZMIZ2 PLSCR3	6.78e-04	196	81	5	4347_DN
Drug	Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A	CCNT2 SETD1B DVL2 TMEM209 LRP6	6.78e-04	196	81	5	7470_DN
Drug	Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A	CASKIN2 TMEM209 TRIOBP LRP6 PLSCR3	6.78e-04	196	81	5	5404_DN
Drug	PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A	NFATC4 ZMIZ2 IQSEC2 DVL2 TJAP1	6.78e-04	196	81	5	3732_UP
Drug	Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; HL60; HT_HG-U133A	ZMIZ2 IQSEC2 ARHGEF9 PLSCR3 HDAC7	6.78e-04	196	81	5	2389_UP
Drug	Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A	GPR137 AMPD3 ZMIZ2 KHDRBS2 LRP6	6.78e-04	196	81	5	6445_DN
Drug	Ofloxacin [82419-36-1]; Down 200; 11uM; PC3; HT_HG-U133A	SETD1A NCOR2 CASKIN2 ZMIZ2 CDON	6.78e-04	196	81	5	3673_DN
Drug	Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; PC3; HT_HG-U133A	GPR137 ZMIZ2 LRP6 HDAC7 CDON	6.78e-04	196	81	5	6619_DN
Drug	Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A	GPR137 CCNT2 ZMIZ2 MED1 TRIM52	6.78e-04	196	81	5	7432_UP
Drug	Timolol maleate salt [26921-17-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A	MYOF CASKIN2 ZMIZ2 IQSEC2 KHDRBS2	6.78e-04	196	81	5	6483_DN
Disease	neurodevelopmental disorder with speech impairment and dysmorphic facies (implicated_via_orthology)	SETD1A SETD1B	7.08e-06	2	79	2	DOID:0070417 (implicated_via_orthology)
Disease	Epilepsy	SETD1A ERN1 KDM5C IQSEC2	2.14e-04	109	79	4	C0014544
Disease	Gastrointestinal Stromal Sarcoma	GLI1 PTCH2 CDON	2.75e-04	47	79	3	C3179349
Disease	glucagon-like peptide-1 measurement	AMBN BICRA	3.14e-04	10	79	2	EFO_0008465
Disease	Gastrointestinal Stromal Tumors	GLI1 PTCH2 CDON	3.31e-04	50	79	3	C0238198
Disease	Diffuse Large B-Cell Lymphoma	GLI1 SPEN CCDC86	4.38e-04	55	79	3	C0079744
Disease	testosterone measurement	CASC3 NCOR2 DDR1 NCOA6 AMPD3 EGR2 IQSEC2 CNKSR3 ARHGEF9 SIN3A PLSCR3	5.73e-04	1275	79	11	EFO_0004908
Disease	vision disorder	THPO RBFOX3	8.29e-04	16	79	2	MONDO_0021084
Disease	colorectal cancer (is_marker_for)	DDR1 GLI1 KDM5C HDAC7	8.50e-04	157	79	4	DOID:9256 (is_marker_for)
Disease	PR interval	ZNF469 CASKIN2 CNKSR3 OBSCN TJAP1 TBX5	2.14e-03	495	79	6	EFO_0004462
Disease	intraocular pressure measurement	MYOF ZNF469 FOLH1 PTCH2 TRIOBP PLEKHA7	2.46e-03	509	79	6	EFO_0004695
Disease	Hodgkins lymphoma, multiple myeloma, chronic lymphocytic leukemia	ELL2 DTNB	2.56e-03	28	79	2	EFO_0000095, EFO_0000183, EFO_0001378

Protein segments in the cluster

Peptide	Gene	Start	Entry
VFNHPLPPPPPVTYQ	CCNT2	661	O60583
PPLPSTYLPISHPPQ	ELL2	376	O00472
QHQLPPVPGSPEPYP	CCDC86	151	Q9H6F5
YSLPVHPPPLPSQPS	AMBN	101	Q9NP70
PLLPPPPQNSVPHYA	DDR1	556	Q08345
YPIPTPGSLPPLHPS	GSE1	281	Q14687
PAPHPYSPQPPPYHE	DVL2	556	O14641
TGQPHLVPVPPLPEY	ATP5PB	36	P24539
ARSVPPSYPPPQDPL	ARHGEF9	461	O43307
PDFHPPPLPQEDPYC	AMPD3	196	Q01432
PPQPSRLAPYPHPAT	ATF5	191	Q9Y2D1
NGIPAEYAPPPPHPT	RBFOX3	16	A6NFN3
LDHLYSPPPPPPPYS	EGR2	161	P11161
PNYFEPPIPRSPHIP	OGFOD1	246	Q8N543
PPSDLYLPPPDHGAP	NCOR2	2176	Q9Y618
PPQPPHPSLSYEPAL	PTPRN	191	Q16849
SPFPIPPQSPAYEPN	NFKBIZ	311	Q9BYH8
TPPHRRDPPPSPTEY	GPR137	356	Q96N19
SPLPLYSPAPQHPPA	IQSEC2	1366	Q5JU85
PPPPGYENVSDIVPP	FOLH1	146	Q04609
PPTARAYPPPHPNQA	CCDC120	86	Q96HB5
PPYPVTPGYPEPALH	PLSCR3	16	Q9NRY6
YPTNPPGQLPSPPHV	MDM1	621	Q8TC05
NYDSEPVPPPPTPRS	LRP6	1561	O75581
PPHPQPLFSHYPQPS	GLI1	841	P08151
ALPPPPPPHQVSYDY	FAM181B	381	A6NEQ2
NGPPQPTPPPHYRLE	CBFA2T3	331	O75081
PQPPAEEPPHPLTYS	CASKIN2	371	Q8WXE0
PALPFLPPTSDPPDH	NUTM1	26	Q86Y26
STYNPHKPVPYPIPP	PROSER1	191	Q86XN7
DPSQPPPPPLQHYLE	OBSCN	5816	Q5VST9
VQTPSHPPPPYPFGS	NCOA6	366	Q14686
LDLEEFVPPVPPPPY	FAM189B	236	P81408
ALPPPPPPHLYPNTQ	CASC3	641	O15234
YFHEPPEPQPPVTPD	ERN1	961	O75460
QVSPPPPYPAPQELT	CRTC3	441	Q6UUV7
SPPPVVPVVAPYPQD	CDON	1131	Q4KMG0
PTREPPHPVFPEQPE	DTNB	311	O60941
PNIHPPQIPATPPSY	IST1	266	P53990
PTVPGYRAPPPPAHE	KHDRBS2	251	Q5VWX1
PVPSLPSDPPEHFPL	HDAC7	136	Q8WUI4
TPASPPPLHRPEAYP	BICRA	1531	Q9NZM4
PPGPQSPEHPPTTIY	C4orf54	1546	D6RIA3
VPAPPSEAPQPPEAH	POLRMT	731	O00411
PLPENPYHSRPRPDP	NDUFA8	136	P51970
HPAVLPGEDPPPYSP	PIP4P1	56	Q86T03
STPPTTYPQPVPHPQ	MED1	746	Q15648
PPPPYQEQVPVPVYH	RNF11	36	Q9Y3C5
PPPEDAPLYPHSPGS	USP9X	2491	Q93008
PPPQPPTPDYTESDI	SHD	16	Q96IW2
PPPNPYPLPQEHSQI	TBX5	306	Q99593
SPPRPPYPSYPHEDP	NFATC4	716	Q14934
PPPLPGAYIHPAPDE	PTCH2	1166	Q9Y6C5
IPEPPPVSFQPYHPL	TENT5D	366	Q8NEK8
PELYSPEDQPPAVPP	PLEKHA7	926	Q6IQ23
SSTVPPPPHRPLYQP	PRRC2C	706	Q9Y520
PYASPRSPPVQPHTP	SIN3A	271	Q96ST3
QTPVAHFPPPPEEPT	SETD1B	401	Q9UPS6
HYQRPASAQPPPPPP	PRR12	291	Q9ULL5
DFLPVVPHPYEPPEP	PROB1	686	E7EW31
PPHQPAYLLPPRPDG	SETD1A	626	O15047
APESEPPHHEPPYIP	TRIOBP	1046	Q9H2D6
PPHHEPPYIPPAVCI	TRIOBP	1051	Q9H2D6
PQASPIPHPHVYQPP	SOX30	581	O94993
IPPPPAVPYSPRDEN	CNK3/IPCEF1	346	G9CGD6
IPPPPAVPYSPRDEN	CNKSR3	346	Q6P9H4
EKLNPYPTPSPPHPL	TJAP1	311	Q5JTD0
YPDIHPPPSLPLPGQ	TRIM52	166	Q96A61
YEPSTPEPPPQVPAL	RBP3	91	P10745
PPPYPGESQTDLQPP	SPEN	2236	Q96T58
NPAPYPAPHLLQPGP	SP7	206	Q8TDD2
PPPVQPLPGTELEHY	ROBO2	1076	Q9HCK4
PPHDLAATQIPPAPP	TMEM209	116	Q96SK2
APLQPPSVPAPSDYP	ZMIZ2	731	Q8NF64
PAADYPTLPPPPLSQ	WASF2	371	Q9Y6W5
PEPPHSLPTHYQPEP	ZNF469	651	Q96JG9
YEIPPITPPNLPEPS	TOX2	76	Q96NM4
PPQPPPPDLSTELYY	ZNF462	1101	Q96JM2
HHIPSPPPAIPYELP	UBXN10	61	Q96LJ8
PELAPTAPLPYPAPE	VPS37B	181	Q9H9H4
VHRPGTPPPPYTVAP	WBP1	131	Q96G27
HRPEPLFIPPPPSYN	TRERF1	656	Q96PN7
PTHELPPYTPPPMLS	TRERF1	701	Q96PN7
PNLQPGYSPSPTHPP	THPO	286	P40225
PEEPPNYPAAPASDP	KDM5C	1321	P41229
KDQSPPPSPPPSYHP	KIAA1522	666	Q9P206
IYPLPDDPSVPAPPR	MYOF	1526	Q9NZM1